本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Prelude Therapeutics Inc

3.05
-0.1900-5.86%
成交量:11.91萬
成交額:36.63萬
市值:1.92億
市盈率:-2.36
高:3.32
開:3.23
低:3.01
收:3.24
52周最高:4.22
52周最低:0.6101
股本:6,286.53萬
流通股本:250.24萬
量比:0.68
換手率:4.76%
股息:- -
股息率:- -
每股收益(TTM):-1.2929
每股收益(LYR):-1.2929
淨資產收益率:-99.45%
總資產收益率:-40.74%
市淨率:2.79
市盈率(LYR):-2.36

資料載入中...

2024/02/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/20

重要事件披露

Form 8-K - Current report
2023/05/18

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/05/17

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report